4 European Projects Found
Searched on 125080 European Projects
FINISHED
My Health - My Data (MH-MD)
Start date: Nov 1, 2016, End date: Oct 31, 2019,
Issues of data subjects’ privacy and data security represent a crucial challenge in the biomedical sector more than in other industries. The current IT landscape in this field shows a myriad of isolated, locally hosted patient data repositories, managed by clinical centres and other organisations, which are subject to frequent and massive data breaches. Patients are disenfranchised in this process ...
Read Project
16
Partners Participants
FINISHED
Personalised Decision Support for Heart Valve Disease (EurValve)
Start date: Feb 1, 2016, End date: Jan 31, 2019,
Valvular Heart Disease currently affects 2.5% of the population, but is overwhelmingly a disease of the elderly and consequently on the rise. It is dominated by two conditions, Aortic Stenosis and Mitral Regurgitation, both of which are associated with significant morbidity and mortality, yet which pose a truly demanding challenge for treatment optimisation. By combining multiple complex modelling ...
Read Project
14
Partners Participants
FINISHED
Proof of Concept of Model-based Cardiovascular Prediction (CARDIOPROOF)
Start date: Oct 1, 2013, End date: Sep 30, 2016,
CARDIOPROOF is a proof-of-concept project that consolidates the outcomes of previous VPH projects and checks the applicability and effectiveness of available predictive modelling and simulation tools, validating them in interrelated clinical trials conducted in three European centres of excellence in cardiac treatment (from Germany, Italy and the UK). CARDIOPROOF focuses on patients with aortic va ...
Read Project
10
Partners Participants
FINISHED
Living autologous heart valves for minimally invasive implantable procedures (LIFEVALVE)
Start date: Nov 1, 2009, End date: Apr 30, 2015,
Cardiovascular disease still represents the Killer No.1 in the EU accounting for substantial morbidity/mortality and health care cost. Heart valve replacement represents the most common surgical therapy for valvular heart disease with almost 200.000 annual implantations worldwide. Currently, heart valve prosthesis-associated problems occur in 30-35% of patients within 10 years, frequently necessit ...
Read Project
